These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3996575)

  • 1. [Effect of delagil on the blood coagulation system and the interrelation with heparin].
    Ovchinnikova LK; Pomortseva IV
    Farmakol Toksikol; 1985; 48(2):77-81. PubMed ID: 3996575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of bigumal on the blood coagulation system and on the anticoagulant effect of heparin].
    kremneva VF; Ushkalova EA; Shcheglova NV
    Farmakol Toksikol; 1986; 49(6):43-5. PubMed ID: 3817142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of the Soviet antimalarial preparation dabequin on the hemostatic system and on the anticoagulant effect of heparin].
    Pomortseva IV; Ovchinnikova LK; Shcheglova NV
    Farmakol Toksikol; 1990; 53(1):59-62. PubMed ID: 2328805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of isoptin on the anticoagulant effect of the sodium and calcium salts of heparin].
    Ushkalova EA; Kremneva VF; Shcheglova NV
    Farmakol Toksikol; 1988; 51(3):48-51. PubMed ID: 3410026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence of ciprofloxacin and pefloxacin on blood coagulation and the anticoagulant effect of heparin].
    Lepakhin VK; Ushkalova EA; Shcheglova NV
    Farmakol Toksikol; 1989; 52(5):33-6. PubMed ID: 2599074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular delagil therapy in malaria.
    Várnay F
    Ther Hung; 1989; 37(4):199-201. PubMed ID: 2698517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the properties of dicoumarin and its compounds with heparin].
    Kudriashov BA; Liapina LA; Zvereva EG
    Vopr Med Khim; 1985; 31(2):79-83. PubMed ID: 2408377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of dibunol and delagil in the treatment of acute pancreatitis].
    Buianov VM; Stupin IV; Zheltikov AN; Sherstnev MP
    Vestn Khir Im I I Grek; 1988 Dec; 141(12):28-32. PubMed ID: 3250058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The blood anticoagulant system in rats perorally administered a heparin-acetylsalicylic acid complex].
    Kudriashov BA; Liapina LA; Pastorova VE; Kondashevskaia MV
    Izv Akad Nauk SSSR Biol; 1991; (4):625-30. PubMed ID: 1787232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antithrombin III activity in relation to multiple administration of various doses of heparin to normal animals].
    Kudriashov BA; Pastorova VE; Liapina LA
    Vopr Med Khim; 1985; 31(3):37-41. PubMed ID: 4024529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interaction of quinidine, lidocaine, tricaine and pyromecaine with heparin].
    Ushkalova EA; Petrov AD; Shcheglova NV
    Farmakol Toksikol; 1989; 52(4):43-5. PubMed ID: 2806526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of prolonged hypocoagulation appearing after intratracheal administration of heparin].
    Efimov VS; Rumiantseva AG; Golovleva OA; Rozkin MIa
    Biull Eksp Biol Med; 1992 May; 113(5):509-12. PubMed ID: 1421273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
    Fonseca RJ; Mourão PA
    Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new route of heparin administration--the lung.
    Kavanagh LW; Jaques LB
    Arzneimittelforschung; 1976; 26(3):389-92. PubMed ID: 989334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of epsilon-aminocaproic acid derivatives on the anticoagulant activity of heparin.
    Midura-Nowaczek K; Bruzgo I; Worowski K; Roszkowska-Jakimiec W
    Rocz Akad Med Bialymst; 1998; 43():228-31. PubMed ID: 9972059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated coagulation time test: a convenient monitor of heparinization for dogs used in cardiovascular research.
    Wilkerson RD; Conran PB; Greene SL
    Lab Anim Sci; 1984 Feb; 34(1):62-5. PubMed ID: 6716959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated coagulation time in monitoring heparinized dogs.
    Green RA
    Am J Vet Res; 1980 Nov; 41(11):1793-7. PubMed ID: 7212408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Action of ratibol on the blood coagulation system].
    Seĭfulla RD; Vaĭsberg MA; Syrov VN
    Farmakol Toksikol; 1986; 49(4):40-2. PubMed ID: 3758326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.